Literature DB >> 30652100

Dipeptidyl peptidase 4 (DPP4), adipose inflammation, and insulin resistance: is it time to look to the hepatocyte?

Wellington S Silva Júnior1, Maria das Graças C Souza2, Luiz Guilherme Kraemer-Aguiar2,3,4.   

Abstract

Entities:  

Year:  2018        PMID： 30652100      PMCID： PMC6295385          DOI： 10.21037/hbsn.2018.10.05

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  3 in total

1.  DPP-4 as a Novel Biomarker for Inflammatory Bowel Disease: Is It Ready for Clinical Use?

Authors:  Courtney Perry; Neeraj Kapur; Terrence A Barrett
Journal:  Inflamm Bowel Dis       Date:  2020-10-23       Impact factor: 5.325

Review 2.  NAFLD as a continuum: from obesity to metabolic syndrome and diabetes.

Authors:  Amélio F Godoy-Matos; Wellington S Silva Júnior; Cynthia M Valerio
Journal:  Diabetol Metab Syndr       Date:  2020-07-14       Impact factor: 3.320

3.  Distal mutation V486M disrupts the catalytic activity of DPP4 by affecting the flap of the propeller domain.

Authors:  Teng-Teng Li; Cheng Peng; Ji-Qiu Wang; Zhi-Jian Xu; Ming-Bo Su; Jia Li; Wei-Liang Zhu; Jing-Ya Li
Journal:  Acta Pharmacol Sin       Date:  2021-12-14       Impact factor: 7.169
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.